Three more biotechs tum­ble on­to Wall Street to­day, rais­ing $475M as the IPO par­ty rocks on

It’s just an­oth­er day in the 2020 biotech IPO boom. Three went pub­lic this morn­ing and a fourth gained 75 per­cent on its Nas­daq trad­ing de­but.

Lead­ing the pack is the bi­o­log­i­cal an­a­lyt­ics-fo­cused com­pa­ny Berke­ley Lights, which priced at $22 per share and raised $178.2 mil­lion. Next up is ALX On­col­o­gy, which at $19 per share raised $161.5 mil­lion. Then comes T-cell biotech Pan­dion, re­vis­ing pre­vi­ous num­bers to $18 per share and of­fer­ing an up­sized 2 mil­lion more shares, rais­ing $135 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.